Page 40 - Read Online
P. 40

Page 2 of 24         Saier et al. J Cancer Metastasis Treat 2021;7:43  https://dx.doi.org/10.20517/2394-4722.2021.87

               Keywords: Lysophosphatidic acid, sphingosine 1-phosphate, eicosanoids, prostaglandins, leukotrienes, cancer,
               bone cells



               INTRODUCTION
               Bone is a highly dynamically regulated tissue which undergoes continuous homeostatic and reactive
               remodeling by the coordinated action of bone cells, namely osteoblasts, osteoclasts, and osteocytes, and
               controlled by endocrine factors, immune cells, and mechanical forces. Sir Paget’s “seed and soil” theory was
               the first still valid concept explaining why certain types of cancers have remarkably high propensity to form
               bone metastases such as breast and prostate cancers . During the 1990s, works released from Greg Mundy’s
                                                           [1]
               lab led to the development of an additional theory leading to the notion of the “vicious cycle” established at
               the sites of bone metastases, reflecting the reciprocal stimulation between tumor growth and bone
                        [2]
               resorption . The vicious cycle theory is also still valid with even more clinical impact, as it is the current
               target of the best systemic therapies against bone metastases that use anti-resorptive agents (i.e.,
               bisphosphonates and denosumab) . Unfortunately, even under these best standards of care, patients with
                                            [3]
               bone metastases still have limited overall survival, indicating the existence of additional molecular
               mechanisms. Bioactive lipids are widely present in the organism and affect almost all vital systems. In this
               review, we focus on two lysophospholipids, lysophosphatidic acid (LPA) and sphingosine 1-phosphate
               (S1P), and two classes of eicosanoids, prostanoids and leukotrienes, because all of these molecules can
               regulate cancer progression including bone metastasis as well as important biological processes directly
               related to bone such as skeletal development, mineralization, regulation of bone mass and homeostasis,
               osteoblast-osteoclast coupling, and bone resorption and formation.


               LYSOPHOSPHATIDIC ACID
               Structure, synthesis, and receptors
               LPA is the simplest phospholipid which is composed of a glycerophosphate backbone linked to a single fatty
               acid chain. LPA can be synthesized from two pathways. In the first one, phospholipid precursors such as
               phosphatidylcholine (PC), phosphatidylserine (PS), or phosphatidylethanolamine (PE) can be converted to
               lysophosphatidylcholine (LPC), lysophosphatidylserine (LPS), and lysophosphatidylethanolamine (LPE),
               respectively, through the action of phosphatidylserine-specific phospholipase A1 or secretory phospholipase
               A2 such as in blood platelets  [Figure 1]. LPC appears to be the most abundant LPA precursor in the
                                        [4,5]
               blood. These precursors can then be converted to LPA by a lysophospholipase D (LysoPLD). LPA can also
               be generated by a distinct mechanism, namely the acylation of glycerol-3-phosphate by glycerophosphate
               acyltransferase and the phosphorylation of monoacylglycerol by monoacylglycerol kinase . LPA level is
                                                                                             [6]
               tightly tuned by degradation mechanisms mediated by different classes of enzymes such as lipid phosphate
               phosphatases (LPPs)  or LPA acyltransferase .
                                [7]
                                                     [8,9]
               Autotaxin (ATX or ENPP2) is responsible for LPA levels in the blood, as evidenced by LPA concentrations
               in serum that are half normal values in Enpp2  heterozygous mice . As a unique member of the family of
                                                                        [10]
                                                      +/-
               the seven ectonucleotide pyrophosphatase/phosphodiesterase (ENPP) that hydrolyze pyrophosphate and
               phosphodiester bonds in nucleotides and their derivatives , ATX possess a LysoPLD activity, allowing the
                                                                [11]
               hydrolysis of LPC and other lipid precursors to produce LPA. ATX is present at high concentration in the
               blood circulation . However, the origin of ATX in blood remains to be determined. Nevertheless, adipose
                              [12]
                                                                           fl/fl
               tissue is likely one of the main sources, as revealed in aP2-Cre/Enpp2  mice presenting 30% decrease in
               LPA levels in plasma . ATX is also highly expressed in the brain and lymphatic high endothelial
                                  [13]
               venules . Although ATX is capable of hydrolyzing nucleotides in vitro, its biological function relies on its
                     [14]
                                                                                                  [15]
               lysoPLD activity, as the apparent affinity for LPC is 10 times higher than that of nucleotides  and as
   35   36   37   38   39   40   41   42   43   44   45